Details for Patent: RE45313
✉ Email this page to a colleague
Summary for Patent: RE45313
Title: | Exendin variant peptides |
Abstract: | The present invention relates to novel peptide conjugates which have increased stability and are useful in the treatment of excess levels of blood glucose. |
Inventor(s): | Larsen; Bjarne Due (Roskilde, DK), Mikkelsen; Jens Damsgaard (Kgs. Lyngby, DK), Neve; Soren (Kgs. Lyngby, DK) |
Assignee: | Zealand Pharma A/S (Glostrup, DK) |
Application Number: | 13/944,735 |
Patent Claim Types: see list of patent claims | Composition; |
Drugs Protected by US Patent RE45313
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent RE45313
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Austria | 242267 | ⤷ Try a Trial | |||
Austria | 551362 | ⤷ Try a Trial | |||
Australia | 2005203735 | ⤷ Try a Trial | |||
Australia | 5966000 | ⤷ Try a Trial | |||
Australia | 781338 | ⤷ Try a Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |